-
1
-
-
39749191084
-
Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
-
(2008)
Circulation
, vol.117
-
-
Rosamond, W.1
Flegal, K.2
Furie, K.3
Go, A.4
Greenlund, K.5
Haase, N.6
Hailpern, S.M.7
Ho, M.8
Howard, V.9
Kissela, B.10
Kittner, S.11
Lloyd-Jones, D.12
McDermott, M.13
Meigs, J.14
Moy, C.15
Nichol, G.16
O'Donnell, C.17
Roger, V.18
Sorlie, P.19
Steinberger, J.20
Thom, T.21
Wilson, M.22
Hong, Y.23
more..
-
2
-
-
0024370594
-
Ischaemic supratentorial stroke: Angiographic findings in patients examined in the very early phase
-
Bozzao L, Fantozzi LM, Bastianello S, Bozzao A, Argentino C, Lenzi GL, Fieschi C. Ischaemic supratentorial stroke: Angiographic findings in patients examined in the very early phase. J Neurol 1989;236:340-342.
-
(1989)
J Neurol
, vol.236
, pp. 340-342
-
-
Bozzao, L.1
Fantozzi, L.M.2
Bastianello, S.3
Bozzao, A.4
Argentino, C.5
Lenzi, G.L.6
Fieschi, C.7
-
3
-
-
41249090658
-
National US estimates of recombinant tissue plasminogen activator use. ICD-9 codes substantially underestimate
-
Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use. ICD-9 codes substantially underestimate. Stroke 2008;39:924-928.
-
(2008)
Stroke
, vol.39
, pp. 924-928
-
-
Kleindorfer, D.1
Lindsell, C.J.2
Brass, L.3
Koroshetz, W.4
Broderick, J.P.5
-
4
-
-
0034161611
-
Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience
-
Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 2000;283:1151-1158.
-
(2000)
JAMA
, vol.283
, pp. 1151-1158
-
-
Katzan, I.L.1
Furlan, A.J.2
Lloyd, L.E.3
Frank, J.I.4
Harper, D.L.5
Hinchey, J.A.6
Hammel, J.P.7
Qu, A.8
Sila, C.A.9
-
5
-
-
0034026360
-
Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria
-
Englestein E, Margulies J, Jeret JS. Lack of t-PA use for acute ischemic stroke in a community hospital: High incidence of exclusion criteria. Am J Emerg Med 2000;18:257-260.
-
(2000)
Am J Emerg Med
, vol.18
, pp. 257-260
-
-
Englestein, E.1
Margulies, J.2
Jeret, J.S.3
-
7
-
-
22044433673
-
MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial
-
Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP, MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005;36: 1432-1438.
-
(2005)
Stroke
, vol.36
, pp. 1432-1438
-
-
Smith, W.S.1
Sung, G.2
Starkman, S.3
Saver, J.L.4
Kidwell, C.S.5
Gobin, Y.P.6
Lutsep, H.L.7
Nesbit, G.M.8
Grobelny, T.9
Rymer, M.M.10
Silverman, I.E.11
Higashida, R.T.12
Budzik, R.F.13
Marks, M.P.14
-
9
-
-
19544385747
-
Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients
-
Yadav JS, Wholey MH, Juntz RE, Fayad P, Katzen BT, Mishkel GJ, Bajwa TK, Whitlow P, Strickman NE, Jaff MR, Popma JJ, Snead DB, Cutlip DE, Firth BG, Ouriel K. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med 2004;351:1943-1501.
-
(2004)
N Engl J Med
, vol.351
, pp. 1943-1501
-
-
Yadav, J.S.1
Wholey, M.H.2
Juntz, R.E.3
Fayad, P.4
Katzen, B.T.5
Mishkel, G.J.6
Bajwa, T.K.7
Whitlow, P.8
Strickman, N.E.9
Jaff, M.R.10
Popma, J.J.11
Snead, D.B.12
Cutlip, D.E.13
Firth, B.G.14
Ouriel, K.15
-
10
-
-
33750042277
-
-
Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lievre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X, EVA-3S Investigators. Endarectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;335:1660-1671.
-
Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, Larrue V, Lievre M, Leys D, Bonneville JF, Watelet J, Pruvo JP, Albucher JF, Viguier A, Piquet P, Garnier P, Viader F, Touzé E, Giroud M, Hosseini H, Pillet JC, Favrole P, Neau JP, Ducrocq X, EVA-3S Investigators. Endarectomy versus stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006;335:1660-1671.
-
-
-
-
11
-
-
33749236625
-
30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomized non-inferiority trial
-
SPACE Collaborative Group
-
SPACE Collaborative Group, Ringleb PA, Allenberg J, Bruckman H, Eckstein HH, Fraedrich G, Hartmann M, Hennerici M, Jansen O, Klein G, Kunze A, Marx P, Niederkorn K, Schmiedt W, Solymosi L, Stingele R, Zeumer H, Hacke W. 30 Day results from the SPACE trial of stent-protected angioplasty versus carotid endarterectomy in symptomatic patients: A randomized non-inferiority trial. Lancet 2006;368:1239-1247.
-
(2006)
Lancet
, vol.368
, pp. 1239-1247
-
-
Ringleb, P.A.1
Allenberg, J.2
Bruckman, H.3
Eckstein, H.H.4
Fraedrich, G.5
Hartmann, M.6
Hennerici, M.7
Jansen, O.8
Klein, G.9
Kunze, A.10
Marx, P.11
Niederkorn, K.12
Schmiedt, W.13
Solymosi, L.14
Stingele, R.15
Zeumer, H.16
Hacke, W.17
|